Current research into rare cancers
Help us beat cancer sooner
Our life-saving work relies on the money you give us.
Donate now and together we can save more lives by beating cancer sooner.
Saving lives through research
We’re determined to make sure rare cancers aren’t overlooked. That’s why we’re funding research and clinical trials for rare cancers, to increase our understanding of their biology and to improve how we treat them. Here are some examples of the work we’re doing right now.
Our current researchers
Testing new drugs
Professor Helena Earl is leading a clinical trial for women with a rare type of womb cancer - high grade sarcoma. The trial, being co-ordinated from Glasgow, aims to find out whether using a new, targeted drug after chemotherapy could improve outlook. The results from the trial could change the way these women are treated in future.
Finding the best combination
Dr Sheela Rao in London is running an international clinical trial to improve treatment for people with advanced anal cancer. The trial aims to figure out which combination of chemotherapy works best for people whose cancer has spread or can’t be removed with surgery. If successful, it could set a new ‘gold standard’ of treatment for the disease.
Stopping cancer's return
Dr Venkata Ramesh Bulusu in Cambridge is running a clinical trial for people with high-risk gastrointestinal stromal tumours who’ve had surgery. It’s testing whether giving these patients a drug called imatinib for five years is better at stopping the tumour coming back compared to giving the drug for three years. The trial is being run in collaboration with other researchers across Europe.
Leading a national clinical trial
Dr Paul Nathan based in London is leading a national clinical trial. It’s testing a new treatment for patients with a rare type of melanoma that occurs in the eye. He is testing different ways of giving a new targeted treatment, either alongside chemotherapy or on its own. The aim is to find the combination that works best.